Delivering on the Promise of Regenerative Medicine
Harbor MedTech, Inc. is a fully integrated, commercial-stage regenerative medicine company with a patented technology. Our BriDGE® platform creates a stabilized collagen matrix that prevents our products from degrading; thus allowing them to heal in as few as one application.
Our first BriDGE® technology product, Architect®, is FDA cleared and CE marked for healing chronic skin wounds. Architect® upregulates the patient’s own immune response to accelerate healing, reduce biofilm formation, and can treat patients in as few as one application.
Leveraging the BriDGE® platform, Harbor MedTech has a robust pipeline, including products that meet significant unmet needs in breast reconstruction, hernia repair, Achilles tendon and rotator cuff repair as well as many other surgical applications.
President & CEO
Chief Technology Officer
Recent News Releases
What’s new in the Harbor MedTech world?
Harbor MedTech Presents the Latest Findings on its Advanced Wound-Healing Technology at the Symposium on Advanced Wound Care and Wound Healing Society Spring Conference
Apr. 10, 2017…IRVINE, Calif.…Harbor MedTech, a commercial-stage regenerative medicine company delivering innovative biologic wound-healing products, presented a Poster on Architect®, its advanced wound-healing product, and BriDGE®, its unique technology. The...read more
Mar. 6, 2017…IRVINE, Calif.…Harbor MedTech, a commercial-stage regenerative medicine company delivering innovative biologic wound-healing products, today announced that Jerry Mezger, President and CEO, will present at the 29th Annual ROTH Conference. The presentation...read more
Come visit Harbor MedTech, Inc. at the Translational to Clinical (T2C) Regenerative Medicine Wound Care Conference at The Ohio State University. March 9-11th, 2017read more